Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients
Abroad (travel likely)RecruitingPHASE1
Conditions
Adenovirus Infection · BK Virus Infection · Cytomegaloviral Infection · Hematopoietic and Lymphoid Cell Neoplasm · JC Virus Infection · Malignant Solid Neoplasm · Symptomatic COVID-19 Infection Laboratory-Confirmed
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
M D Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (May Daher, MD)
Study leads
May Daher, MD
Principal Investigator
M.D. Anderson Cancer Center